All surgeries ended with 4-0 vicryl and 3-0 vicryl (Ethicon) sutures to sew up the abdominal wall and the skin, respectively
Nutrition Strategies for Next-Generation Incretin Therapies: A Systematic Scoping Review of the Current Evidence Obesity Reviews, 2026
the project category is Natural Science Fund, and the project nos
FDA Removes GHK-Cu from Category 2: What Peptide Users Need to Know On April 15, 2026, the FDA announced a significant regulatory update: injectable GHK-Cu (copper tripeptide-1) will be removed from the Category 2 bulk substances list by July 2026
The documented considerations include mild water retention (a class effect of raising GH), injection-site reactions, occasional headache or lightheadedness, and most importantly for long-term thinking IGF-1 and sustained-GH-elevation considerations, which are why cycling with breaks is favored over indefinite use
Any side effects must be carefully considered and weighed up against the side effects of not taking medications